Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
ArQule now operates as a wholly-owned subsidiary of Merck, as the deal concluded.ArQule is primarily focused on the research and development of targeted ... Feb 26
-Advertisements-